AKT1 and prostate cancer: Similar to PtenloxP/loxP; PB4-Cre, the deletion of Inpp4b alone is insufficient for the development of invasive prostate cancer, despite increased phosphorylation levels of Akt [5,24] and increased prostate inflammation [25].